Literature DB >> 35181198

Tau liquid-liquid phase separation in neurodegenerative diseases.

Solomiia Boyko1, Witold K Surewicz2.   

Abstract

Aggregation of the microtubule-associated protein tau plays a major role in Alzheimer's disease and several other neurodegenerative disorders. An exciting recent development is the finding that, akin to some other proteins associated with neurodegenerative disease, tau has a high propensity to condensate via the mechanism of liquid-liquid phase separation (LLPS). Here, we discuss the evidence for tau LLPS in vitro, the molecular mechanisms of this reaction, and the role of post-translational modifications and pathogenic mutations in tau phase separation. We also discuss recent studies on tau LLPS in cells and the insights these studies provide regarding the link between LLPS and neurodegeneration in tauopathies.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  liquid–liquid phase separation; neurodegenerative diseases; protein aggregation; protein condensation; tau

Mesh:

Substances:

Year:  2022        PMID: 35181198      PMCID: PMC9189016          DOI: 10.1016/j.tcb.2022.01.011

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   21.167


  89 in total

1.  FLEXITau: Quantifying Post-translational Modifications of Tau Protein in Vitro and in Human Disease.

Authors:  Waltraud Mair; Jan Muntel; Katharina Tepper; Shaojun Tang; Jacek Biernat; William W Seeley; Kenneth S Kosik; Eckhard Mandelkow; Hanno Steen; Judith A Steen
Journal:  Anal Chem       Date:  2016-03-07       Impact factor: 6.986

2.  A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation.

Authors:  Avinash Patel; Hyun O Lee; Louise Jawerth; Shovamayee Maharana; Marcus Jahnel; Marco Y Hein; Stoyno Stoynov; Julia Mahamid; Shambaditya Saha; Titus M Franzmann; Andrej Pozniakovski; Ina Poser; Nicola Maghelli; Loic A Royer; Martin Weigert; Eugene W Myers; Stephan Grill; David Drechsel; Anthony A Hyman; Simon Alberti
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

Review 3.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

Review 4.  Matter over mind: Liquid phase separation and neurodegeneration.

Authors:  Shana Elbaum-Garfinkle
Journal:  J Biol Chem       Date:  2019-03-26       Impact factor: 5.157

5.  FTDP-17 tau mutations induce distinct effects on aggregation and microtubule interactions.

Authors:  Benjamin Combs; T Chris Gamblin
Journal:  Biochemistry       Date:  2012-10-18       Impact factor: 3.162

6.  IUPred2A: context-dependent prediction of protein disorder as a function of redox state and protein binding.

Authors:  Bálint Mészáros; Gábor Erdos; Zsuzsanna Dosztányi
Journal:  Nucleic Acids Res       Date:  2018-07-02       Impact factor: 16.971

7.  Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type.

Authors:  S Flament; A Delacourte; M Verny; J J Hauw; F Javoy-Agid
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Structure-based classification of tauopathies.

Authors:  Yang Shi; Wenjuan Zhang; Yang Yang; Alexey G Murzin; Benjamin Falcon; Abhay Kotecha; Mike van Beers; Airi Tarutani; Fuyuki Kametani; Holly J Garringer; Ruben Vidal; Grace I Hallinan; Tammaryn Lashley; Yuko Saito; Shigeo Murayama; Mari Yoshida; Hidetomo Tanaka; Akiyoshi Kakita; Takeshi Ikeuchi; Andrew C Robinson; David M A Mann; Gabor G Kovacs; Tamas Revesz; Bernardino Ghetti; Masato Hasegawa; Michel Goedert; Sjors H W Scheres
Journal:  Nature       Date:  2021-09-29       Impact factor: 49.962

9.  ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function.

Authors:  Tetsuro Murakami; Seema Qamar; Julie Qiaojin Lin; Gabriele S Kaminski Schierle; Eric Rees; Akinori Miyashita; Ana R Costa; Roger B Dodd; Fiona T S Chan; Claire H Michel; Deborah Kronenberg-Versteeg; Yi Li; Seung-Pil Yang; Yosuke Wakutani; William Meadows; Rodylyn Rose Ferry; Liang Dong; Gian Gaetano Tartaglia; Giorgio Favrin; Wen-Lang Lin; Dennis W Dickson; Mei Zhen; David Ron; Gerold Schmitt-Ulms; Paul E Fraser; Neil A Shneider; Christine Holt; Michele Vendruscolo; Clemens F Kaminski; Peter St George-Hyslop
Journal:  Neuron       Date:  2015-10-29       Impact factor: 17.173

10.  Disease-Associated Tau Phosphorylation Hinders Tubulin Assembly within Tau Condensates.

Authors:  Adriana Savastano; David Flores; Harindranath Kadavath; Jacek Biernat; Eckhard Mandelkow; Markus Zweckstetter
Journal:  Angew Chem Int Ed Engl       Date:  2020-11-09       Impact factor: 16.823

View more
  4 in total

Review 1.  Liquid-liquid phase separation as an organizing principle of intracellular space: overview of the evolution of the cell compartmentalization concept.

Authors:  Iuliia A Antifeeva; Alexander V Fonin; Anna S Fefilova; Olesya V Stepanenko; Olga I Povarova; Sergey A Silonov; Irina M Kuznetsova; Vladimir N Uversky; Konstantin K Turoverov
Journal:  Cell Mol Life Sci       Date:  2022-04-20       Impact factor: 9.261

2.  Recent trends in studies of biomolecular phase separation.

Authors:  Chan-Geun Kim; Da-Eun Hwang; Rajeev Kumar; Min Chung; Yu-Gon Eom; Hyunji Kim; Da-Hyun Koo; Jeong-Mo Choi
Journal:  BMB Rep       Date:  2022-08       Impact factor: 5.041

Review 3.  Biochemical Pathways of Cellular Mechanosensing/Mechanotransduction and Their Role in Neurodegenerative Diseases Pathogenesis.

Authors:  Ilaria Tortorella; Chiara Argentati; Carla Emiliani; Francesco Morena; Sabata Martino
Journal:  Cells       Date:  2022-10-01       Impact factor: 7.666

Review 4.  Liquid-Liquid Phase Separation Promotes Protein Aggregation and Its Implications in Ferroptosis in Parkinson's Disease Dementia.

Authors:  Mengzhu Li; Yaohua Fan; Qinglian Li; Xiaoling Wang; Lijun Zhao; Meiling Zhu
Journal:  Oxid Med Cell Longev       Date:  2022-10-06       Impact factor: 7.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.